A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-48816274
Clinical trial NCT02852395 · COMPLETED
Trial details
- NCT number
- NCT02852395
- Sponsor
- Janssen-Cilag International NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-13
- Primary completion
- 2018-05-02
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.